Douglass Winthrop Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Buy
4,310
+2,388
+124% +$711K 0.02% 145
2025
Q4
$634K Buy
1,922
+212
+12% +$71.8K 0.01% 193
2025
Q3
$590K Sell
1,710
-316
-16% -$95.6K 0.01% 193
2025
Q2
$632K Sell
2,026
-9,662
-83% -$3.69M 0.01% 176
2025
Q1
$6.12M Sell
11,688
-83,739
-88% -$42.8M 0.12% 66
2024
Q4
$48.3M Sell
95,427
-131,732
-58% -$74.8M 0.94% 32
2024
Q3
$133M Buy
227,159
+410
+0.2% +$232K 2.53% 13
2024
Q2
$115M Buy
226,749
+11,291
+5% +$5.53M 2.36% 14
2024
Q1
$107M Buy
215,458
+6,487
+3% +$3.3M 2.19% 21
2023
Q4
$110M Buy
208,971
+245
+0.1% +$131K 2.46% 16
2023
Q3
$105M Buy
208,726
+4,556
+2% +$2.24M 2.61% 11
2023
Q2
$98.1M Buy
204,170
+6,766
+3% +$3.31M 2.34% 16
2023
Q1
$93.3M Buy
197,404
+11,493
+6% +$5.55M 2.42% 15
2022
Q4
$98.6M Buy
185,911
+2,025
+1% +$1.07M 2.7% 12
2022
Q3
$92.9M Buy
183,886
+2,458
+1% +$1.29M 2.8% 12
2022
Q2
$93.2M Buy
181,428
+3,432
+2% +$1.72M 2.62% 11
2022
Q1
$90.8M Buy
177,996
+65,155
+58% +$31.4M 2.14% 17
2021
Q4
$56.7M Buy
112,841
+99,698
+759% +$45.1M 1.27% 31
2021
Q3
$5.13M Sell
13,143
-266
-2% -$110K 0.13% 66
2021
Q2
$5.37M Sell
13,409
-135
-1% -$53.8K 0.13% 60
2021
Q1
$5.04M Sell
13,544
-3,021
-18% -$1.05M 0.14% 59
2020
Q4
$5.81M Buy
16,565
+67
+0.4% +$22.5K 0.17% 51
2020
Q3
$5.14M Sell
16,498
-1,996
-11% -$613K 0.17% 53
2020
Q2
$5.46M Sell
18,494
-678
-4% -$194K 0.2% 46
2020
Q1
$4.78M Sell
19,172
-11,265
-37% -$3.1M 0.21% 47
2019
Q4
$8.95M Sell
30,437
-1,192
-4% -$312K 0.32% 48
2019
Q3
$6.87M Buy
31,629
+708
+2% +$171K 0.26% 51
2019
Q2
$7.54M Sell
30,921
-245
-0.8% -$58.9K 0.3% 49
2019
Q1
$7.71M Sell
31,166
-3,493
-10% -$891K 0.34% 50
2018
Q4
$8.63M Buy
34,659
+184
+0.5% +$48.6K 0.43% 41
2018
Q3
$9.17M Sell
34,475
-1,308
-4% -$340K 0.41% 44
2018
Q2
$8.78M Buy
35,783
+90
+0.3% +$21.6K 0.39% 46
2018
Q1
$7.64M Buy
35,693
+29,187
+449% +$6.67M 0.37% 53
2017
Q4
$1.43M Sell
6,506
-474
-7% -$100K 0.08% 107
2017
Q3
$1.37M Buy
6,980
+930
+15% +$180K 0.08% 107
2017
Q2
$1.12M Hold
6,050
0.07% 113
2017
Q1
$992K Sell
6,050
-1,453
-19% -$238K 0.06% 119
2016
Q4
$1.2M Buy
7,503
+1,425
+23% +$213K 0.08% 111
2016
Q3
$851K Buy
6,078
+284
+5% +$39.8K 0.06% 124
2016
Q2
$818K Hold
5,794
0.06% 127
2016
Q1
$747K Hold
5,794
0.05% 131
2015
Q4
$682K Buy
5,794
+1,278
+28% +$149K 0.05% 144
2015
Q3
$524K Hold
4,516
0.04% 154
2015
Q2
$534K Hold
4,516
0.04% 162
2015
Q1
$534K Buy
4,516
+730
+19% +$81.1K 0.04% 162
2014
Q4
$383K Buy
3,786
+251
+7% +$23.8K 0.03% 153
2014
Q3
$305K Buy
3,535
+235
+7% +$19.9K 0.03% 163
2014
Q2
$270K Hold
3,300
0.02% 165
2014
Q1
$271K Hold
3,300
0.03% 164
2013
Q4
$248K Sell
3,300
-150
-4% -$10.8K 0.03% 161
2013
Q3
$247K Hold
3,450
0.03% 155
2013
Q2
$226K Buy
+3,450
New +$215K 0.03% 161

Other funds holding UNH

Douglass Winthrop Advisors's UNH Position: Q1 2026 in Review

Douglass Winthrop Advisors increased its UnitedHealth (UNH) stake by 124% in Q1 2026, buying an estimated $711K and bringing the position to 4,310 shares worth $1.17M. The position accounts for 0.02% of the portfolio, ranked #145.

Douglass Winthrop Advisors first reported a position in UNH in Q2 2013 and has held it in 52 quarters since. The position peaked at $133M in Q3 2024. 3,018 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Douglass Winthrop Advisors held 4,310 shares of UnitedHealth worth $1.17M as of Q1 2026.
  • Douglass Winthrop Advisors bought 2,388 UnitedHealth shares in Q1 2026, an estimated $711K.
  • UnitedHealth made up 0.02% of Douglass Winthrop Advisors's portfolio in Q1 2026, its #145 holding.
  • Douglass Winthrop Advisors first reported a position in UnitedHealth in Q2 2013 and has held it in 52 quarters since.
  • Douglass Winthrop Advisors's UnitedHealth position peaked at $133M in Q3 2024.
  • 3,018 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Douglass Winthrop Advisors's 13F filing for Q1 2026, filed 14 May 2026.